Cargando…
Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine
SIMPLE SUMMARY: Our research focuses in the elucidation of the nature of circulating cell-free DNA (ccfDNA) as a biological entity and its exploitation as a liquid biopsy biomaterial. Working on breast cancer, it became clear that although a promising biosource, its clinical exploitation is burdened...
Autores principales: | Panagopoulou, Maria, Esteller, Manel, Chatzaki, Ekaterini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916622/ https://www.ncbi.nlm.nih.gov/pubmed/33578793 http://dx.doi.org/10.3390/cancers13040728 |
Ejemplares similares
-
Label-Free Human Disease Characterization through Circulating Cell-Free DNA Analysis Using Raman Spectroscopy
por: Papadakis, Vassilis M., et al.
Publicado: (2023) -
Autotaxin in Breast Cancer: Role, Epigenetic Regulation and Clinical Implications
por: Drosouni, Andrianna, et al.
Publicado: (2022) -
ENPP2 Methylation in Health and Cancer
por: Panagopoulou, Maria, et al.
Publicado: (2021) -
Somatic copy number aberrations detected in circulating tumor DNA can hold diagnostic value for early detection of hepatocellular carcinoma
por: Chatzaki, Ekaterini, et al.
Publicado: (2020) -
Deciphering the Methylation Landscape in Breast Cancer: Diagnostic and Prognostic Biosignatures through Automated Machine Learning
por: Panagopoulou, Maria, et al.
Publicado: (2021)